In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Kura Oncology Inc (NASDAQ: KURA) was $7.28 for the day, down -5.58% from the previous closing price of $7.71. In other words, the price has decreased by -$5.58 from its previous closing price. On the day, 0.89 million shares were traded. KURA stock price reached its highest trading level at $7.93 during the session, while it also had its lowest trading level at $7.28.
Ratios:
Our analysis of KURA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.39. For the most recent quarter (mrq), Quick Ratio is recorded 9.46 and its Current Ratio is at 9.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $27.
Stifel Downgraded its Buy to Hold on October 14, 2024, whereas the target price for the stock was revised from $26 to $19.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 28 ’25 when DOYLE THOMAS JAMES sold 4,949 shares for $7.87 per share. The transaction valued at 38,958 led to the insider holds 88,193 shares of the business.
Leoni Mollie sold 4,963 shares of KURA for $39,068 on Jan 28 ’25. The Chief Medical Officer now owns 88,253 shares after completing the transaction at $7.87 per share. On Jan 28 ’25, another insider, Bair Teresa Brophy, who serves as the Chief Legal Officer of the company, sold 7,281 shares for $7.87 each. As a result, the insider received 57,315 and left with 107,948 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 587896448 and an Enterprise Value of -122904880. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.91 while its Price-to-Book (P/B) ratio in mrq is 1.38. Its current Enterprise Value per Revenue stands at -2.281 whereas that against EBITDA is 0.639.
Stock Price History:
The Beta on a monthly basis for KURA is 0.75, which has changed by -0.6741271 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, KURA has reached a high of $23.48, while it has fallen to a 52-week low of $6.79. The 50-Day Moving Average of the stock is -8.39%, while the 200-Day Moving Average is calculated to be -53.05%.
Shares Statistics:
KURA traded an average of 1.65M shares per day over the past three months and 1419350 shares per day over the past ten days. A total of 78.23M shares are outstanding, with a floating share count of 75.15M. Insiders hold about 6.94% of the company’s shares, while institutions hold 96.10% stake in the company. Shares short for KURA as of 1740700800 were 9211838 with a Short Ratio of 5.60, compared to 1738281600 on 8075542. Therefore, it implies a Short% of Shares Outstanding of 9211838 and a Short% of Float of 11.5200005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
